We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our
Cookie Policy
.
Accept
Label
Search
SKIP TO CONTENT
SKIP NAVIGATION
Drug News
Trending
Commercial Operations
GMPs
FDA Enforcement Actions
Inspections and Audits
Postmarket Safety
Quality
Regulatory Affairs
Research and Development
Submissions and Approvals
FDAnews
Device News
Trending
Commercial Operations
FDA Enforcement Actions
Inspections and Audits
Postmarket Safety
Quality
Regulatory Affairs
Research and Development
Submissions and Approvals
FDAnews
Books
FDAnews Books Library
Drug Books
Device Books
Training/Events
Webinar Training Pass
Events
Webinar Recordings
Resources
Form 483s Database
FDA Approved Drugs
CenterWatch
WCG Clinical
Sign In
Create Account
Sign Out
My Account
Home
»
Authors
» Robert M. Barbosa
Robert M. Barbosa
Products
PRODUCTS
Univ. of Wisconsin Radiopharmaceutical Production Facility
Robert M. Barbosa
and
Charles L. Zhou
Price:
$117.00
View
KP Pharmaceutical Technology
Robert M. Barbosa
Price:
$117.00
View
Natural Pharmaceutical Manufacturing, Inc.
Robert M. Barbosa
Price:
$117.00
View
Fresenius Kabi Oncology, Ltd.
Robert M. Barbosa
and
Jose E. Melendez
Price:
$117.00
View
PD Pharmatech
Robert M. Barbosa
Price:
$117.00
View
PD Pharmatech
Robert M. Barbosa
Price:
$117.00
View
Pharmakon Compounding Pharmacy, Inc.
Robert M. Barbosa
,
Bei Y. He
, and
Emily J. Orban
Price:
$117.00
View
Medivative Technologies, LLC
Robert M. Barbosa
and
Debara R. Reese
Price:
$117.00
View
Monosol Rx, LLC
Robert M. Barbosa
and
Pratik S. Upadhyay
Price:
$117.00
View
American Family Pharmacy, LLC
Robert M. Barbosa
Price:
$117.00
View
View All Products by Robert M. Barbosa
Upcoming Events
21
Oct
MAGI@home Clinical Research Conference 2024
Featured Products
From QSR to QMSR: Meeting FDA’s New Requirements
FDA Oversight of Laboratory-Developed Tests — The Impact of the Final Rule
Featured Stories
Risk of 10 Obesity-Driven Cancers Reduced by GLP-1s, Study Says
Three Device Areas Added to CDRH’s Device-Advancing TAP Program
Third Alzheimer’s Drug Gets FDA Approval, Just as Diagnostic Criteria Expand
Draft Guidance Covers Using URRAs in Combo Product Applications
The Revised ICH E8:
A Guide to New Clinical Trial Requirements
Learn More
